469 Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by two different ELISA methods  by unknown
S124 Journal of Cystic Fibrosis 4 (2005) Sl19 S125 
466 
Management of CF patients aged 0-3 years and its impact on their 
future development 
V. S kalickfi 1, D. Zemkov~ 1,L. Smolikov~ 1,H. Chladov~ 1, L. Pelikfin 1, T. Ku~er ov~ 1, 
A. Holeikov~ , V. V~vrov~ 1 
~NationaI CF Centre, Cku~rles University - 2 '~ School of Medicine am] University 
Hospital Motol, Prague, Czech Republic, 2Regional CF Centre, Masatyk University 
- School of Medicine arm University Hospital Brno, Czech R public 
Introduct ion:  The period between 0 3 is critical for the future development in CF 
patients. Adequate patient management comprising of: a) complete laboratot3~ 
examinations, chest X ray, abdominal ultrasonogr aphy, microbiological cultivation 
and PCR basvxl detection of /~ aeruginosa nd B. cepacia, nutritional status 
determination and caloric intake calculation, b) proper parental education with 
emphasis on airway clearance techniques, nutrition, hygienic rules, c) immediate 
initiation of intensive treatment a d d) complete CF team support, is thus essential 
from the moment of diagnosis. 
A ims:  To analyse future development of patients wi th different levels of 
complications at the moment of diaguosis. 
Methods:  45 CF patients born 1998 2CO2 were divided into 3 groups: A)  meconium 
ileus (n 10); other complications B1) serious (11); B2) mild (24). Nutrit ional 
status was evaluated at the t ime of diaguosis and during 2CO4 5 when a lung 
function test was performed. 
Results:  Patients from group A and B 1 were diagnosed younger with more obvious 
signs of growth retardation i  comparison with B2. Recently the nutritional status 
of these 3 groups does not significantly differ (body weight SDS A 0 .6+1.3 ,  B1 
0 .4+0.8 ,  B2 0 .1+1)  Lung function (LF) tests are available in 22 patients; they 
show normal LF in group A and B 1. In B 2 two of 10 had MEF25 <60% predicted. 
Conclus ion:  Appropriate patient management  leads to the same level  of 
compensation regardless of the initial type and seriousness of complications. 
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Prevalence of atopy in children with cystic fibrosis 
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Aim The aim of the study was to asses prevalence of atopy in pateints with cystic 
fibrosis 
Methods Skin prick test with 3 allergens (Allergopharma): Dermatophagoides 
pteronyssinus (dl),  Aspergillus fumigatus (m3), mi lk  (t2) as wel l  as level of specific 
IgE (for the same allergens) mad total IgE were done. SPT were positive when mean 
diameter of wheal  was at least 3 mm and equal or greater than histamine wheal.  
Increasvxl levels of IgE were estimated according to own labor atot3, normal ranges. 
Atopy was diagnosed when at least one of tests (SPT, specific IgE, total IgE) was 
positive. 
Results The study group comprised 101 CF patients treated in our Dept. in the years 
2CO2 2CO4, aged 2 31 (mean age 15,1). Diaguosis of CFwas conf i rmedbegenet ic  
examination. 
Prevalence of positive results 
Allergen Positive SPT algE>0.35 U/ml 
Dermatophagoidez pt. (d 1) 14.7% 57.4% 
Azpergilluz flmaigatuz (m3) 2.9% 16.8% 
Milk (f~) 0,0% 6.9% 
Total IgE 99,8 
Totally in our ~up patients with CF prevalence of atopy was 67,3 %. 
Conclusions The prevalence of atopy in patients uffering from CF is over 3 t ime 
higher than in general  population in  Poland. Data from the mult icentre 
epidemiological study comprising 11713 adults aged 17 80 mad 2988 children aged 
2 16 shows that prevalence of allergy in adult is 15,8% and ha children 19,2%. 
These surprising results pointing out for taking into account problems of allergy in 
diaguosis mad treatment of patients with CF. Further study with aim to determine 
whether genetic background or heavy bacterial colonization is responsible for such 
a high prevalence of atopy ha these group of patients is under way. 
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Aims:  Description of interesting epidemiological, genotypic and phenotypic 
characteristics of cystic fibrosis among Greek Cypriots 
Methods:  Records review of all CF Greek Cypriot patients mad personal 
interviewing (where applicable). 
Results:  During the past 12 years we  diaguosed 27 CF patients, 25 of whom are 
alive. With a population of ~ 65C(~), CF mutation carrier frequency is estimated to 
be ~ 1/80. In patients of greek cypriot descent the most frequent mutation is 
AF508del, accounting for 45% of mutant alleles. The second most frequent 
mutation is L346P (14%), carried by 7 of the patients in heter ozygosity. Apparently 
this is a Cypriot mutation, as it has not been repotted in other populations. We 
reckon it is a mild mutation dominating over the severe one, as patients cart3'ing it 
have mi lder phenotypes. Other mutations found are: 1677delTA (6%), 
3849+ 10kbC>T, (4%), $549N (4%), W1282X (4%), N1303K (4%), M348K (2%), 
2789+5G>A (2%),G542X (2.1%), Unknown (12%). About half  of our patients 
(47.6%), presented at diaguosis with dehydration and electrolytic disturbance 
during summer months, ha addition, 77.3% of our patients experienced at least one 
episode of dehydration and electrolyte imbalance in their l i fetime with most of these 
episodes (88%) requiring hospitalization. 
Conclusions: CF mutation frequency ha &/pros is lower than in other European 
countries. The burden of the disease seems also to be milder since classic severe 
mutations are rarer. Dehydrat ion mad electrolyte imbalance episodes are 
encountered at a much higher f equency than reported from elsewhere. 
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Aims mad Methods.  Sera from 948 CF patients participating in Scandinavian 
l~aeruginosa prevalence study were collected The patients were considered 
cbronically infected when either the level of precipitins against PA was >2 or PA 
was cultured from respir atot3, tract secretion at least hree times in the last 6 months. 
Two ELISA methods were used (exotoxin A ELISA (exoA) and IgG subclass 
ELISA (lgGsub) using the polyvalent PA antigen) and thek sensitivity mad 
specificity in diaguosis of cbr onic PA infection were evaluated. 
Results. 308 patients have never been cultured positive for PA; median age 10.7 
years (range 0 .473  years) and median level of PA antibodies were 40  EU (10 460) 
and 0.56 EU (0.02 3.4) respectively for exoA and IgGsub. 248 patients were 
intermittently colonized by PA; median age 12 years (0.25 63.8) and median 
antibody levels 80 EU (5 2300) and 0.83 EU (0.04 25). The differences between 
non colonized mad intermittently colonized patients were not significant. 392 
patients were cbronically infected with PA. The median age mad antibody levels 
were 25.1 years (2.6 59.7), 417 EU (25~i2CO)) and 35.7 EU (0.03 589.9) 
respectively. This group was significantly older and had higher levels of specific 
anti PA antibodies. Sensitivity of ExoA and IgGsub ELISA were 80.6% mad 91% 
respectively, specificity were 88.5% and 88.9%. The negative predictive values 
were 86.6% and 93.1% and positive predictive value were 83.2% and 85.8% 
respectively. 
Conclusion. Both methods turned out to be both highly specific mad sensitive. 
Specific anti l~aeruginosa antibodies should be measured at regular intervals 
coupled with more aggressive anti pseudomonal treatment of patients wi th 
increasing levels to prevent he cbr onic infection. 
